Not applicableStudy completedNCT02725801What this trial is testingComparison of One-port and Two-port Tissue Expanders for Breast ReconstructionWho this might be right forBreast Cancer Lesley Wong 20
Not applicableLooking for participantsNCT06722612What this trial is testingChemotherapy Combined With Targeted Therapy for High-risk HER2 Positive and Lymph Node Negative Early Breast CancerWho this might be right forHER2-positive Breast Cancer Shu Wang 2,916
Testing effectiveness (Phase 2)Study completedNCT05280067What this trial is testingZETAMET™ BONE GRAFT IN THE REPAIR OF BONE DEFECTS FROM METASTATIC BREAST CANCER IN VERTEBRAL BONESWho this might be right forMetastatic Breast Cancer in the Spine Zetagen Therapeutics, Inc 10
Large-scale testing (Phase 3)Study completedNCT01619111What this trial is testingDETECT III - A Multicenter, Phase III Study to Compare Standard Therapy +/- Lapatinib in HER2-ve MBC-Patients With HER2+ve CTCsWho this might be right forHER2-negative Metastatic Breast CancerHER2-positive Circulating Tumor Cells Prof. Wolfgang Janni 105
Not applicableUnknownNCT06106711What this trial is testingThe Impact of Adverse Events, Produced by Antibodies Conjugates, on Quality of Life in Patients With Metastatic Breast Cancer: Multicentric, Observational Study (EVA).Who this might be right forMetastatic Breast Cancer Centro di Riferimento Oncologico - Aviano 92
Not applicableStudy completedNCT04436809What this trial is testingSentinel Node Biopsy Alone or With Axillary Dissection After Primary ChemotherapyWho this might be right forBreast Neoplasm Female Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 353
Early research (Phase 1)Ended earlyNCT01334099What this trial is testingSafety Study of Radiation and CP-675,206 Infusion for Breast Cancer PatientsWho this might be right forMetastatic Breast Cancer University Health Network, Toronto 6
Large-scale testing (Phase 3)Study completedNCT00256698What this trial is testingAnastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination TherapyWho this might be right forBreast Cancer AstraZeneca 514
Not applicableEnded earlyNCT00651716What this trial is testingT Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell TransplantWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+8 more Vanderbilt-Ingram Cancer Center 150
Testing effectiveness (Phase 2)Looking for participantsNCT06086704What this trial is testingStudy of 18F-FFNP Breast PET/MRIWho this might be right forBreast Cancer University of Wisconsin, Madison 53
Testing effectiveness (Phase 2)Study completedNCT00546104What this trial is testingPhase II Dasatinib Study in Advanced Breast CancerWho this might be right forAdvanced Breast Cancer Duke University 31
Not applicableStudy completedNCT04161833What this trial is testingOpera® for Aromatase Inhibitor-related Arthralgia Management (AIA)Who this might be right forBreast CancerHormone Receptor Positive TumorArthralgia Azienda Ospedaliero-Universitaria Careggi 53
Not applicableUnknownNCT05726162What this trial is testingEffects of Biofeedback-based Music Program Using a Smart Device Application on Perioperative Sleep QualityWho this might be right forSleep Quality Seoul National University Hospital 68
Not applicableStudy completedNCT00214162What this trial is testingCHESS Caregivers Study: Web-based Support for Informal Caregivers in CancerWho this might be right forBreast CancerProstate Cancer University of Wisconsin, Madison 235
Not applicableUnknownNCT06134570What this trial is testingALDH1A1 Expression in Invasive Mammary CarcinomaWho this might be right forBreast Cancer Sohag University 60
Not applicableNo Longer AvailableNCT03706573What this trial is testingManaged Access Program to Provide Alpelisib for Patients With HR+ Advanced or Metastatic Breast CancerWho this might be right forHR+ Advanced or Metastatic Breast Cancer Novartis Pharmaceuticals
Not applicableLooking for participantsNCT03436069What this trial is testingIdentification of New Prognostic Markers for Breast Cancer.Who this might be right forBreast Cancer University Hospital, Grenoble 1,500
Testing effectiveness (Phase 2)Ended earlyNCT04190056What this trial is testingPembrolizumab and Tamoxifen With or Without Vorinostat for the Treatment of Estrogen Receptor Positive Breast CancerWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Prognostic Stage IV Breast Cancer AJCC v8 University of California, San Francisco 1
Early research (Phase 1)Study completedNCT02392611What this trial is testingStudy to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Alobresib (Formerly GS-5829) in Adults With Advanced Solid Tumors and Lymphomas and in Combination With Exemestane or Fulvestrant in Adults With Estrogen Receptor Positive Breast CancerWho this might be right forSolid Tumors and Lymphomas Gilead Sciences 33
Not applicableActive Not RecruitingNCT05941299What this trial is testingSafety and Performance of REGENERA Breast Implant in Women Affected by Malignant Breast Lesion Treated by LumpectomyWho this might be right forMastectomy, SegmentalBreast Neoplasm Malignant Female Tensive SRL 92